Rock Point Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07M Buy
1,786,681
+596,525
+50% +$1.89M 1.1% 37
2025
Q4
$4.76M Buy
1,190,156
+211,707
+22% +$1.18M 1.19% 36
2025
Q3
$8.28M Buy
978,449
+128,489
+15% +$1.25M 2.19% 16
2025
Q2
$9.57M Buy
849,960
+25,425
+3% +$234K 2.7% 10
2025
Q1
$7.81M Buy
824,535
+225,396
+38% +$2.28M 2.41% 13
2024
Q4
$6.74M Buy
599,139
+133,357
+29% +$2.34M 1.96% 19
2024
Q3
$13.2M Sell
465,782
-26,605
-5% -$686K 3.6% 6
2024
Q2
$9.41M Buy
492,387
+140,780
+40% +$3.6M 2.82% 10
2024
Q1
$11.5M Sell
351,607
-31,904
-8% -$1.02M 3.42% 5
2023
Q4
$12.7M Buy
383,511
+8,240
+2% +$233K 3.84% 5
2023
Q3
$10.2M Buy
375,271
+44,823
+14% +$1.25M 3.54% 5
2023
Q2
$10M Sell
330,448
-21,359
-6% -$691K 3.29% 7
2023
Q1
$11.4M Sell
351,807
-3,544
-1% -$112K 3.88% 3
2022
Q4
$9.98M Buy
355,351
+30,510
+9% +$875K 3.45% 6
2022
Q3
$11.7M Sell
324,841
-8,800
-3% -$310K 4.34% 3
2022
Q2
$10.2M Sell
333,641
-57,973
-15% -$1.69M 3.5% 4
2022
Q1
$12.6M Buy
391,614
+2,535
+0.7% +$66.4K 3.77% 3
2021
Q4
$10.8M Sell
389,079
-26,011
-6% -$746K 3.03% 7
2021
Q3
$12.9M Sell
415,090
-69,875
-14% -$1.68M 3.77% 4
2021
Q2
$10.2M Buy
484,965
+55
+0% +$1.1K 2.95% 8
2021
Q1
$9.79M Sell
484,910
-46,795
-9% -$890K 3.05% 8
2020
Q4
$8.52M Sell
531,705
-29,789
-5% -$394K 2.93% 12
2020
Q3
$6.97M Sell
561,494
-106,699
-16% -$1.25M 3.09% 13
2020
Q2
$4.76M Sell
668,193
-79,120
-11% -$530K 2.22% 14
2020
Q1
$4.06M Buy
747,313
+214,815
+40% +$1.92M 2.41% 16
2019
Q4
$4.82M Sell
532,498
-93,217
-15% -$757K 1.96% 20
2019
Q3
$4.5M Buy
625,715
+191,230
+44% +$1.37M 2.03% 21
2019
Q2
$3.45M Buy
434,485
+191,455
+79% +$2.27M 1.57% 27
2019
Q1
$3.06M Buy
+243,030
New +$3.85M 1.44% 29

Other funds holding EVH